Actos Litigation

Actos (pioglitazone) is an oral medication used to control blood sugar in type 2 diabetes. Actos is manufactured by Takeda Pharmaceuticals and is the 14th most sold medication in the United States. On June 15, 2011, the FDA issued a safety announcement stating that use of Actos® for over a year may be associated with an increased risk of bladder cancer.

As of June 10, 2011 Germany and France have both halted the sale of Actos after a 4 year study yielded a 22% increased risk of bladder cancer. The French Medicines Agency ordered French doctors not to prescribe Actos and anyone currently taking Actos should consult with his/her doctor immediately. Germany has recommended not to start Actos in new patients.

Bladder Cancer is not only the second most common urologic cancer, but the fourth most common cancer in men. Bladder cancer may spread to nearby areas or lymph nodes throughout the body.  Common signs and symptoms of bladder cancer include: pain while urinating, blood in the urine, back or abdominal pain, and urinary urgency.

If you were prescribed Actos and have been diagnosed with bladder cancer, contact us today to speak with an attorney.

Back to Practice Area »